M. Inoue et al. / Phytochemistry 70 (2009) 1195–1202
1201
4.15. 9-oxo-16-b-[(
D
-xylopyranosyl)oxy]hexadecanoic acid (13)
m/z 1621 [MÀH]À, 1489 [MÀ132ÀH]À, 1459 [MÀ162ÀH]À, 1343
[MÀ132À146ÀH]À; Acid hydrolysis in the same manner as
described above gave 9a. Alkaline hydrolysis of 8 gave 9b. Mild
alkaline hydrolysis with 0.5 (w/v)% KOHaq also gave 9-oxo-16-b-
White powder; [
a
]
D +48.5° (c 0.3, MeOH); 1H NMR (pyridine-d5)
d 1.26–1.41 (12H, m, H-4, H-5, H-6, H-12, H-13 and H-14), 1.58
(8H, m, H-3, H-7, H-11 and H-15), 2.15 (2H, t, J = 7.6 Hz, H-2),
2.43 (4H, m, H-8 and H-10), 3.15 (1H, dd, J = 7.5, 9.2 Hz, H-2 of
Xyl), 3.18 (1H, dd, J = 10.3, 11.4 Hz, H-5a of Xyl), 3.31 (1H, dd,
J = 8.7, 9.2 Hz, H-3 of Xyl), 3.48 (1H, d, J = 5.3, 8.7, 10.3 Hz, H-4 of
Xyl), 3.51 (1H, dt, J = 9.6, 6.7 Hz, H-16a), 3.80 (1H, dt, J = 9.6,
6.7 Hz, H-16b), 3.84 (1H, dd, J = 5.2, 11.4 Hz, H-5b of Xyl), 4.19
(1H, d, J = 7.5 Hz, H-1 of Xyl); 13C NMR (pyridine-d5) d 24.8 (C-7),
24.9 (C-11), 25.9 (C-3), 29.8 (C-4), 30.1 (C-5), 30.2 (C-6, C-12 and
C-13), 30.7 (C-14 and C-15), 34.0 (C-2), 43.3 (C-8 and C-10), 66.9
(Xyl-5), 70.9 (C-16), 71.2(Xyl-4), 74.9(Xyl-2), 77.9 (Xyl-3), 105.1
(Xyl-1), 178.4 (C-1), 214.5 (C-9); HRFABMS (positive-ion mode)
m/z 441.2488 [M+Na]+ (calcd. 441.2464 for C21H38O8Na); Acid
hydrolysis of 13 (10 mg) gave 14 (5 mg).
[(D-xylopyranosyl)oxy]hexadecanoic acid (13).
4.20. Brine shrimp lethality assay
The bioassay was performed in the similar way described in ref-
erence (Meyer et al., 1982; Anderson et al., 1991; Solis et al., 1993;
Carballo et al., 2002). Brine shrimp eggs (Japan Pet Drugs Co., To-
kyo, Japan) were hatched in artificial sea water prepared with com-
mercial salt mixture (Senju Phamaceutical Co., Osaka, Japan) and
oxygenated with an aquarium pump. After 48 h incubation at
28 °C, nauplii were collected with pasteur pipette after attracting
the organisms to one side of vessel with a light source. Ten shrimps
were transferred to each sample vial, and artificial sea water was
added to make 2.5 mL. Samples for testing were made up to
1 mg/mL in artificial sea water (2.5 mL) except for water insoluble
4.16. Preparation of methyl 16-trimethylsilyloxy-8/9-
oxohexadecanoate for EIMS
samples which were dissolved in 50 lL DMSO prior to adding sea
water. Sample solutions (2.5 mL) were added to each test vial (fi-
nally, total 5 mL). The vials were maintained under illumination.
Survivors were counted after 2 and 24 h, and the percent deaths
at each dose and control were determined. DMSO in this concen-
tration did not affect this bioassay. The LC50 values were deter-
mined from 24 h counts using the probit analysis. The results are
summarized in Table 3.
Trimethylsilyldiazomethane (20
solution (100 L) of compounds 11 or 14 (1 mg). After 1 h, the sol-
vent was removed from the reaction mixture, and then added
TMSI-H (100 L) to the residue. After 15 min, H2O (1 drop) was
added to stop the reaction, and the reaction mixture was extracted
with n-hexane. The organic layer furnished methyl 16-trimethylsi-
lyloxy-8/9-oxohexadecanoate (12 and 15, respectively).
lL) was added to an EtOH
l
l
Acknowledgements
4.17. Compound 9 (alkaline treatment product of Physenoside S7 (7)
and S8 (8) with 2.5% NaOHaq)
This work was supported by Grants-in-Aid for Scientific Re-
search (B) (14380289 and 15390013) from the Japan Society for
the Promotion of Science.
White powder; [a]
D +6.9° (c 1.0, MeOH); for 13C NMR (pyridine-
d5) assignments of the glycosidic parts, see Table 2. 13C NMR
(pyridine-d5) data of the aglycone: d 13.9 (C-24), 16.8 (C-25),
17.2 (C-26), 20.9 (C-6), 23.7 (C-11), 24.4 (C-30), 26.8 (C-27), 30.5
(C-20), 31.6 (C-22), 32.8 (C-29), 33.0 (C-7), 35.6 (C-15), 35.7 (C-
21), 36.5 (C-10), 40.2 (C-8), 41.3 (C-18), 42.0 (C-14), 44.1 (C-1),
47.0 (C-19), 47.5 (C-9), 49.3 (C-17), 52.3 (C-5), 52.6 (C-4), 69.8
(C-2), 73.4 (C-16), 85.6 (C-3), 122.3 (C-12), 144.2 (C-13), 175.7
(C-28), 180.9 (C-23); FABMS (negative ion mode) m/z 1221
[MÀH]À, 1089 [MÀ132ÀH]À, 1059 [MÀ162ÀH]À, 943
[MÀ132À146ÀH]À, 649 [MÀ132Â3À146ÀH]À; HRFABMS (posi-
tive-ion mode) m/z 1245.5562 [M+Na]+ (calcd. for 1245.5516
C57H90O28Na).
References
Anderson, J.E., Goetz, C.M., McLaughlin, J.L., Suffness, M., 1991. A blind comparison
of simple bench-top bioassays and human tumour cell cytotoxicities as
antitumor prescreens. Phytochem. Anal. 2, 107–111.
Cao, S., Norris, A., Miller, J.S., Ratovoson, F., Birkinshaw, C., Andriantsiferana, R.,
Rasamison, V.E., Rakotonandrasana, S., Kingston, D.G., 2006. Cytotoxic
compounds of Physena madagascariensis from the Madagascar rain forest
paragraph sign. Nat Prod. Res. 20, 1157–1163.
Carballo, J.L., Hernández-Inda, Z.L., Pérez, P., García-Grávalos, M.D., 2002.
A
comparison between two brine shrimp assays to detect in vitro cytotoxicity in
marine natural products. BMC Biotechnol. 2, 17.
Deas, A.H.B., Baker, E.A., Holloway, P.J., 1974. Identification of 16-
hydroxyoxohexadecanoic acid monomers in plant cutins. Phytochemistry 13,
1901–1905.
Deng, Y., Jiang, T.Y., Sheng, S., Tianasoa-Ramamonjy, M., Snyder, J.K., 1999.
Remangilones A–C, new cytotoxic triterpenes from Physena madagascariensis.
J. Nat. Prod. 62, 471–476.
Deng, Y., Lee, J.P., Tianasoa-Ramamonjy, M., Snyder, J.K., Des Etages, S.A., Kanada, D.,
Snyder, M.P., Turner, C.J., 2000. New antimicrobial flavanones from Physena
madagascariensis. J. Nat. Prod. 63, 1082–1089.
4.18. Physenoside S7 (7)
White powder; [a]
+5.2° (c 1.0, MeOH); for 1H NMR spectro-
D
scopic (pyridine-d5) assignments, see Table 1, and for 13C NMR
(pyridine-d5) assignments of the glycosidic parts: see Table 2; 13C
NMR data of the aglycone were almost the same (within
0.2 ppm) as those for compound 9; FABMS (negative ion mode)
m/z 1621 [MÀH]À, 1489 [MÀ132ÀH]À, 1459 [MÀ162ÀH]À, 1343
[MÀ132À146ÀH]À; Acid hydrolysis in the same manner as
described above gave 9a. Alkaline hydrolysis of 7 gave 9b. Mild
alkaline hydrolysis with 0.5 (w/v)% KOHaq also gave 8-oxo-16-b-
Dickison, W.C., Miller, R.B., 1993. Morphology and anatomy of the malagasy genus
Physena (Physenaceae), with a discussion of the relationships of the genus.
Adansonia 1–4, 85–106.
Dimbi, M.Z., Warin, R., Delaude, C., Huls, R., Kapundu, M., 1984. Structure of
zanhic acid and zanhic acid gamma-lactone,
Zanha golungensis and Ganophyllum giganteum. Bull. Soc. Chim. Belg. 93, 323–
328.
2 novel triterpenoids from
Jurenitsch, J., Lichtenberger, E., Robien, W., Jentzsch, K., 1986. About the
constituents of Giant Golden Rod. Planta Med. 52, 236–238.
Kasai, R., Okihara, M., Asakawa, J., Mizutani, K., Tanaka, O., 1979. 13C NMR study of
[(
4.19. Physenoside S8 (8)
White powder. [ ]
+1.2° (c 1.5, MeOH); for 1H NMR spectro-
D
D-xylopyranosyl)oxy]hexadecanoic acid (10).
a- and b-anomeric pairs of
D-mannopyranosides and L-rhamnopyranosides.
Tetrahedron 35, 1427–1432.
Kasai, R., Miyakoshi, M., Matsumoto, K., Nie, R.L., Zhou, J., Morita, T., Tanaka, O.,
1986. Tubeimoside I, a new cyclic bisdesmoside from Chinese cucurbitaceous
folk medicine ‘‘tu bei mu”, a tuber of Bolbostemma paniculatum. Chem. Pharm.
Bull. (Tokyo) 34, 3974–3977.
Kitagawa, I., Hori, K., Sakagami, M., Hashiuchi, F., Yoshikawa, M., Ren, J., 1993.
Saponin and sapogenol. XLIX. On the constituents of the roots of Glycyrrhiza
inflata Batalin from Xinjiang, China. Characterization of two sweet oleanane-
a
scopic (pyridine-d5) assignments, see Table 1, and for 13C NMR
(pyridine-d5) assignments of the glycosidic parts, see Table 2. 13C
NMR data of the aglycone were almost the same (within
0.2 ppm) as those for compound 9; FABMS (negative ion mode)